Join our network to give paediatric oncology a stronger voice in Europe!
SIOP Europe, the European Society of Paediatric Oncology (SIOPE) aims to ensure the best possible care and outcome for all children and young people with cancer in Europe. It is the only pan-European professional organisation of its kind and the office is based at the heart of EU policy and decision-making, in Brussels, Belgium. |
As a society, SIOPE needs a direct access to the paediatric oncology community in Europe, the foundation and driving force of our organisation, and kindly invites you to join our network!
1. Why should I join SIOPE?
2. What are the advantages for my National Society?
3. Who are the members of SIOPE?
4. Practicalities of SIOPE membership
5. More information
1. Why should I join SIOPE?
Be part of a Europe-wide network
SIOPE is part of a powerful, multidisciplinary network. It is a member of:
ECCO – the European CanCer Organisation (Founding Member)
SIOP – International Society of Paediatric Oncology (Continental Branch)
EURORDIS – Rare Diseases Europe
EFGCP – European Forum for Good Clinical Practice
Rare Cancers Europe
Council of European Rare Disease Federations
Moreover, SIOPE has close ties with parent and patient advocates through ICCCPO (the International Confederation of Childhood Cancer Parent Organisations) and the ECCO Patient Advisory Committee.
Hear about updates and initiatives in your field first
A quarterly SIOPE e-newsletter and regular email communications inform members on the latest news, events, educational opportunities, EU health policies and funding opportunities.
Avail of reduced rates at conferences
You can attend the biennial European Multidisciplinary Cancer Congress, the largest European cancer congress of-its-kind, at a reduced rate. SIOPE will lead the Paediatric Oncology Track of this Congress and ensure our members’ expertise is presented. This high-level multi-stakeholder meeting will open many doors for the paediatric oncology community, as it is the right platform where synergies and cross-fertilisation of expertisewith other sectors take place.
Be actively involved and showcase your initiatives
You will participate in our advocacy initiatives at EU level. Any relevant initiatives, campaigns or news carried out by members at national level can be promoted through SIOPE’s communication channels
Participate in education and training initiatives
You will be regularly informed about educational opportunities.
Collaborate with your European colleagues
You will avail of cross-talk on key issues, share knowledge on issues affecting the entire community and learn about EU projects and funding opportunities.
Network with the pharmaceutical industry
SIOPE will encourage collaborations between academic and commercial research and can create opportunities for you to meet potential pharmaceutical partners.
2. What are the advantages for my National Society?
By becoming a member of SIOPE through your national society, you will increase the influence of your society and the overall ‘critical mass’ of the European paediatric oncology community in Europe.
SIOPE will ensure your needs are addressed. The added-value of working at pan-European level in this field is clear:
European collaborations
Your national society will provide its experience and expertise on any relevant issue. Partnerships are necessary to ensure your issues are addressed and best practices are shared with other national societies.
Influence the EU decision-making process
SIOPE represents the position of its members on EU health and research policies and legislation (e.g. EU Clinical Trials legislation or the Paediatric Regulation), through regular meetings with key decision-makers from the EU institutions and the European Medicines Agency (EMA).
3. Who are the members of SIOPE?
SIOPE will have full, affiliated and honorary members.
The SIOPE membership is based on already established European National Paediatric Haemato-Oncology Societies or groups (‘NaPHOS’), which encourage their members to become part of the SIOPE network.
In countries where no such NaPHOS exists, medical institutions and treatment centres specialised in cancer care for children and young people can join and allow the paediatric oncology professionals in their institute to become members of SIOPE. To ensure an open and ever-expanding community, professionals who are not members of a NaPHOS can also join[1].
SIOPE membership:
Full membership
€20 contribution.
Full members have all the above mentioned benefits, including voting rights.
Affiliate membership
No financial contribution but:
No voting rights
Fewer benefits
Honorary membership
No financial contribution but:
No voting rights
Fewer benefits
4. Practicalities of SIOPE membership
Payment
· NaPHOS will gather the per head SIOPE membership contribution of its full members at the national level;
· The total amount will be transferred once a year, in January, to the below listed SIOPE Bank Account;
· In case SIOPE full membership applicants do not belong to a NaPHOS, they will directly pay their fee to SIOPE
For more information, please contact the office at office<at>siope.eu (please replace <at> with @)
Date
The SIOPE membership will run from January 1st to December 31st of every year.
Signature
The SIOPE membership application forms provided by SIOPE must be signed, sent back to your NaPHOS secretariat (normal postal courier or scanned) and then transferred collectively to SIOPE either in hard copy or electronically (scanned signed application of each member). Another option is to send us the forms through an electronic membership secure portal/intranet (if in place within the National Society).
5. More information
For more information please contact the office at office<at>siope.eu (please replace <at> with @)